Epicure 50mg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Epirubicin (50mg)
Overview Epicure 50mg Injection
Epirubicin 50mg injection treats various hematological malignancies, breast, gastric, pulmonary, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy regimens. Dosage and frequency are determined by your physician, based on your condition and may vary. Strict adherence to the prescribed regimen is crucial, as incorrect usage can lead to severe adverse reactions. Therapeutic benefits might not be apparent immediately; discontinue only under medical supervision. This medication can compromise contraceptive efficacy; reliable birth control is advised for both partners. Frequent side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and rash. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood tests, including kidney, liver, and heart function monitoring, are essential. Pre-treatment disclosure of liver or heart conditions and a complete medication list are vital, as drug interactions can affect efficacy or mechanism. Inform your doctor of pregnancy or breastfeeding.
Uses of Epicure 50mg Injection
Malignancy
Major Benefits of Epicure 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Epicure 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epicure 50mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Epicure 50mg Injection works:
Epigen 50mg Injection is a chemotherapeutic agent targeting breast cancer. Its mechanism involves inhibiting topoisomerase II, a crucial enzyme in DNA replication within breast cancer cells. This inhibition, coupled with the induction of cytotoxic free radicals, leads to DNA damage, ultimately hindering tumor growth and inducing cancer cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Epicure 50mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Epicure 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the inherent dangers. Seek medical advice before use.
Breast feedingUNSAFE
Administering Epicure 50mg Injection while breastfeeding poses a significant risk. Evidence indicates potential infant toxicity from the medication.
DrivingUNSAFE
The administration of Epicure 50mg Injection may induce side effects, including nausea and vomiting, potentially impacting driving capabilities. These episodes of nausea and vomiting could temporarily restrict safe driving.
KidneySAFE IF PRESCRIBED
The use of Epicure 50mg Injection in individuals with kidney impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, a physician's consultation is recommended. For patients exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages should be evaluated.
LiverCAUTION
Patients with liver impairment should receive Epicure 50mg Injection with close monitoring; dosage modification may be necessary. Consult a physician before administration. Epicure 50mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Epicure 50mg Injection :
NA
Facts to Know About Epicure 50mg Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Cytotoxic alkaloids |
3,018 People bought this recently